Helsinki, Finland

Pekka J Kairisalo


Average Co-Inventor Count = 6.8

ph-index = 5

Forward Citations = 209(Granted Patents)


Company Filing History:


Years Active: 1981-1995

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Pekka J Kairisalo

Introduction: Pekka J Kairisalo is a distinguished inventor based in Helsinki, Finland. With an impressive portfolio of seven patents, he has made significant contributions to the field of pharmacologically active compounds. His work primarily focuses on developing innovative drug formulations and compounds that serve as effective inhibitors for various biological processes.

Latest Patents: Among his latest patents, Kairisalo has developed compounds that are pharmacologically active catechol derivatives. One notable patent involves a compound represented by a specific chemical formula where various substitutions are made to enhance efficacy. The compounds described are designed to serve as Catechol-O-methyltransferase (COMT) inhibitors, which are essential for various therapeutic applications. Additionally, Kairisalo has patented methods for the preparation of catechol compounds that demonstrate effectiveness in inhibiting this enzyme, maintaining their relevance in pharmaceutical compositions.

Career Highlights: Throughout his career, Pekka J Kairisalo has been affiliated with Orion-yhtymä Oy, where he has significantly contributed to the company’s innovative edge in the pharmaceuticals sector. His research and inventions have positioned the company as a key player in developing cutting-edge therapeutic solutions.

Collaborations: Kairisalo has worked alongside notable colleagues such as Erkki J Honkanen and Aino K Pippuri. Their collaborative efforts have led to advancements in understanding pharmacological interactions and improving therapeutic efficacy through innovative drug design.

Conclusion: Pekka J Kairisalo exemplifies the spirit of innovation in the pharmaceutical field. With his extensive work on catechol derivatives and COMT inhibitors, he continues to influence the development of effective therapeutic compounds. His career reflects a commitment to enhancing healthcare through groundbreaking inventions, underscoring the importance of collaboration and research in the pursuit of scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…